baber/WOPTO huggingface dataset:
Patent FI-861385-A0 (FI)
Inventor: GAROFF THOMAS
IPC: C08F10/00
Filed: 1986-04-01
Abstract: A catalyst component for an alpha-olefin polymerization catalyst (comprising an organoaluminium compound, an external electron donor and a solid catalyst component obtained by reacting a magnesium-containing compound with a titanium halogen compound) is prepared by the steps of:   (a) dissolving a natural or synthetic mineral containing magnesium and aluminium in hydrochloric acid;   (b) evaporating the solution until dry: (c) calcining the resultant salt mixture by heating it at 130-150 DEG C to convert the aluminium component into the hydroxy form;   (d) dissolving the magnesium component in ethanol; (e) drying the ethanolic solution of the magnesium component by periodic azeotropic distillation; (f) precipitating a solid carrier component from the ethanol solution; and (g) reacting the solid carrier component with a titanium halogen compound in the presence of an internal electron donor or without an electron donor. g
Patent FI-862234-A0 (FI)
Inventor: VENTURELLO CARLO
IPC: C07D241/24
Filed: 1986-05-27
Abstract: A process for the preparation of 2-carboxypyrazine 4-oxides having the formula (I)wherein R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub>, which may be the same or different, represent a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms, by oxidation of the corresponding 2-carboxypyrazines. The 2-carboxypyrazines are reacted under stirring with an aqueous solution of H<sub>2</sub>O<sub>2</sub>, at a pH ranging between 0.5 and 5, in the presence of a catalyst selected from the group consisting of tungstic acid, a homopolytungstic acid, a heteropolytungstic acid, molybdic acid, a homopolymolybdic acid, a heteropolymolybdic acid, and an alkali metal salt thereof.
Patent FI-864935-A0 (FI)
Inventor: CORTLEVER NICO GERHARD
IPC: E02D3/10
Filed: 1986-12-02
Abstract: A device for inserting into the ground a drainage wick (17) consisting of a profiled core and water permeable sleeve, said device consisting mainly of a mobile machine (1) such as a backhoe, with a mast (2), and attached to the mast a rectangular tube (3), holding a drainage wick (17), and being able to move up and down along the mast (2) in a vertical manner, wherein the tube (3) enveloping the wick (17) is inserted into the ground by a pair of hydraulic cylinders (7, 8) supported on the mast (2) and bearing a sheave carrier (9) for a flexible attachment like a cable (14, 16) fastened to said tube (3) so achieving a two times or a multiple insertion speed, in comparison with the capacity or stroke of the cylinders (7, 8) thus shortening the time needed to insert the tube (3).
Patent FI-870686-A0 (FI)
Inventor: GASSNER THEO
IPC: B25C1/18
Filed: 1987-02-19
Abstract: An explosive powder charge operated fastening member driving tool has a muzzle part which can be locked within and released and removed from the tool housing by rotational movement and axial movement relative to the housing. When the tool is not ready to be fired, a contact pressure sensor projects from the front end of the muzzle part. By pressing the sensor opposite to the firing direction it compresses a firing mechanism spring and the tool is ready to be fired. Stop elements are provided on the muzzle part and stop surfaces are located on the tool housing. When the muzzle part is in the unlocked condition, the stop elements can abut the stop surfaces and block the displacement of the contact pressure sensor preventing it from compressing the firing spring mechanism so that the driving tool cannot be placed in the ready-to-fire condition.
Patent FI-883489-A0 (FI)
Inventor: CERCEK BORIS
IPC: G01N33/569
Filed: 1988-07-22
Abstract: The method of the present invention comprises contacting a suspension of viable lymphocytes with a solution containing a membrane potential sensitive fluorescent dye. The contact between the lymphocyte suspension and the MPS dye is maintained for sufficient time to permit labelling of the lymphocytes by the MPS dye material. The labelled lymphocytes are passed individually through a focused source of excitation energy causing any MPS dye material to fluoresce. The fluorescent emission from each cell is recorded as a pulse and the number of pulses of each intensity are recorded. The distribution of the number of pulses versus the intensity is prepared distribution is bimodal. A first peak includes pulses of low fluorescence intensity and a second peak comprises pulses of high fluorescence intensity. A ratio of the total counts of low fluorescence intensity to the total counts of high fluorescence intensity produces a factor which distinguishes lymphocytes derived from bodies afflicted with malignancy from bodies which are not afflicted with malignancy.
Patent FI-913341-A0 (FI)
Inventor: EHMIG GERHARD
IPC: B25C1/14
Filed: 1991-07-10
Abstract: The powder-actuated fastener driving tool has a barrel (11) and a breechblock (17) which are axially displaceable in a housing (1). Provided on the housing (1), on the one hand, and on the barrel (11) and on the breechblock (17), on the other hand, are mutually co-operating stops (3a, 17e) and shoulders (8b, 11e), which first limit the displacement of the barrel (11) and, after a further displacement path, the displacement of the breechblock (17) counter to the driving direction. A free space, which permits the supply, normal to the barrel axis, of propelling charges (15), in particular in magazines, thereby results between the barrel (11) and breechblock (17). 
<IMAGE>
Patent FI-921534-A0 (FI)
Inventor: SUN KAI
IPC: B65D25/54
Filed: 1992-04-07
Abstract: The tubes of this invention are deformable and will usually not be collapsible. The tubes have a view window (16,33) and a elongated nozzle (20,32). The tubes can be made by blow molding or extrusion. The view window permits a person to determine the contents remaining in the tube and the nozzle provides for ease in dispensing. <IMAGE>
Patent FI-921674-A0 (FI)
Inventor: JOANICOT MATHIEU
IPC: D21H19/58
Filed: 1992-04-14
Abstract: Aqueous paper-coating composition with an alkaline pH of between 4 and 7, comprising:   - an insoluble and alkali-nonswellable polymer latex A which has a mean particle diameter OA of between 60 and 300 nm, - an insoluble, alkali-swellable polymer latex B which has a particle diameter OB of between 20 and 150 nm measured at pH of between 2 and 4 and capable of swelling at least 1.5 times in diameter in an alkaline medium, - an inorganic pigment C containing at least 40 % by weight of CaCO3.
Patent FI-935200-A0 (FI)
Inventor: BAYER MICHAEL
IPC: B28B1/24
Filed: 1993-11-23
Abstract: In a ceramic or powder-metallurgical forming mass (moulding composition) which contains waxes as binder, the addition of an ethylene-vinyl acetate copolymer, an organic peroxide, an azo-ester and an alcohol in combination with an extraction with a solvent leads to an improvement in the dimensional stability and the dewaxing of injection-moulded shaped parts.
Patent FI-935295-A0 (FI)
Inventor: JAERVENPAEAE VILJO
IPC: B04C5/18
Filed: 1993-11-29
Abstract: PCT No. PCT/FI94/00482 Sec. 371 Date Jul. 10, 1996 Sec. 102(e) Date Jul. 10, 1996 PCT Filed Oct. 25, 1994 PCT Pub. No. WO95/14535 PCT Pub. Date Jun. 1, 1995A method and apparatus for improving the separation efficiency of a cyclone separator intended for gaseous medium flows in which an incoming gaseous medium flow to be cleansed is directed into the cyclone separator through an inlet duct such that the incoming medium flow ends up in a downward, revolving flow movement inside the cyclone separator until the incoming medium flow reaches a bottom end of a conical lower part of the cyclone separator, and then becomes a revolving tornado flow that flows in a generally upward direction opposite to the direction of the downward, revolving flow movement. An outlet flow of cleansed gaseous medium is directed through a center pipe situated in the cyclone separator. A component-flow pipe is arranged in the center pipe such that the component-flow pipe has an inlet opening in a wall of the center pipe. A component flow of the incoming medium flow is passed from a location within the cyclone separator through the inlet opening in the wall of the center pipe into the component-flow pipe directed out of the component-flow pipe against the tornado flow such that the component flow disintegrates the tornado flow and thereby prevents solid matter from being carried along with the tornado flow through the center pipe into the outlet flow of the cleansed medium flow.
Patent FI-951792-A0 (FI)
Inventor: ELLIOTT STEVEN G
IPC: C07H21/04
Filed: 1995-04-13
Abstract: The following are new: (1) an analogue of human erythropoietin (hEPO) comprising a sequence including \-1 additional glycosylation site; (2) an analogue of hEPO comprising a sequence with re-arrangement of \-1 glycosylation site; (3) a DNA sequence encoding the hEPOs of (1) and (2); and (4) a eukaryotic host cell transfected with the DNA of (3).
Patent FI-955038-A0 (FI)
Inventor: KLOPPSTECK GERD
IPC: A47J27/12
Filed: 1995-10-23
Abstract: A set (10) of stackable pots has a plurality of pots that can be space-savingly nested into each other, in particular cooking pots (12, 14, 16, 18, 20) of various sizes. At least some of the cooking pots are provided with handles (56), and their diameter and height decrease from the lowest (12) to the uppermost pot (20) of the stack. When the pots are placed into each other, each pot is directly or indirectly supported on the upper edge of the underlying pot by its diametrically opposed handles (56) located in the area of its upper edge.
Patent FI-962705-A0 (FI)
Inventor: KREBS MARTIN
IPC: G02C5/00
Filed: 1996-07-01
Abstract: PCT No. PCT/AT94/00205 Sec. 371 Date Jul. 18, 1996 Sec. 102(e) Date Jul. 18, 1996 PCT Filed Dec. 28, 1994 PCT Pub. No. WO95/18987 PCT Pub. Date Jul. 13, 1995A clip lens attachment consists of a bow which connects to rings. The rings are made of a flexible material which can be shrunk in order to adjust its size. The lenses thus attached may be of almost any shape, as the rings can be shrunk to fit the attachment lenses. A hook is attached at each end of the bow for clipping the upper portion of the clip on lens attachment to the frames. Additional hooks are provided on the rings to provide attachment points at the bottom or sides. The ends of the bow and the lower hooks are embedded in the material which forms the rings. With such a device, separate styles of clip on attachments need not be designed for each style spectacles.
Patent FI-982303-A0 (FI)
Inventor: CHENG ROBERTA C
IPC: A61K49/00
Filed: 1998-10-23
Abstract: A group of functionalized polyaminocarboxylate chelants that form complexes with rare earth-type metal ions are disclosed. The complexes can be covalently attached to an antibody or antibody fragment and used for therapeutic and/or diagnostic purposes.
Patent FI-990982-A0 (FI)
Inventor: KOJO TEPPO
IPC: B65H19/22
Filed: 1999-04-30
Abstract: The invention relates to a method and apparatus in a reeling process of a paper web. A paper web (PR) is continuously reeled around a reeling core (10) via a roll assembly (T). A first press device arrangement (8) is arranged to move with respect to the frame (16) of the reel-up and by means of the first press device arrangement (8) a first nip contact (N1) is maintained to the paper web (PR) that is being formed on the reeling core, and the first press device arrangement (8) is transferred with respect to the frame (16) of the reel-up into a nip contact (N2) with a second press device arrangement (11). According to the invention, the section of the roll assembly (T) before the first press device arrangement (8) and the first press arrangement (8) are formed as separate units. The paper web (PR) is guided immediately into nip contact (N1) in the first press device arrangement (8) via the roll assembly (T) stationary with respect to the frame (16) of the reel-up. Furthermore, the paper reel (5) that is being formed and the first press device assembly are transferred as a combination substantially in the travel direction of the paper web (PR) in a position controlled manner.
Patent IL-78571-A0 (IL)
Title: Novel human tissue plasminogen activator mutants
IPC: C12N15/70
Filed: 1986-04-21
Abstract: Human tissue plasminogen activator (t-PA) mutant (I) is produced by recombinant cells and is resistant to specific enzymatic cleavage. (I) is esp. in single-chain form, stabilised by site-directed mutagenesis at a 2-chain cleavage site. Partic. the matural Arg at position 275 is replaced by Gly or Glu, or Ila at position 276 is replaced. Also new are (1) DNA sequences coding for (I); (2) expression vectors able to express (I) and (3) microorganisms and cell cultures transformed with these vectors. A native t-PA gene, contg. the sequence to be mutated, is inserted into the phage M13mp8, and the single-strand form of the prod. annealed to a synthetic oligonucleotide, co-ng. 1 or more triplets coding for the amino acid(s) to be substd. forming a double-strand region. Expression vectors contg. the new DNA sequences can be expressed in E.coli or partic. cultures of Chinese hamster ovary (using vectors which include the SV40 origin of replication as promoter). -
Patent IL-87175-A0 (IL)
Title: Piperidine derivatives,their preparation and their application in therapy
IPC: A61K31/505
Filed: 1988-07-21
Abstract: A compound which is a piperidine derivative of formula (I)    <IMAGE> (I)  in which: n is 1, 2, 3 or 4, R is hydrogen or a halogen, R', which is identical to R, is hydrogen or a halogen, either R1 is H or OH and R2 is H, or R1 and R2 together denote a bond, R3 is hydrogen or (C1-4) alkyl, and R4 is H or OH, including tautomeric forms thereof, or a pharmaceutically acceptable acid addition salt thereof.
Patent IL-93732-A0 (IL)
Title: N-acyl derivatives of the ll-33288 antitumor antibiotics
IPC: A61P35/02
Filed: 1990-03-13
Abstract: The invention is N-acyl and dihydro-N-acyl analogs of the family of antibacterial and antitumor agents known collectively as the E33288 complex.
Patent FI-20055362-A0 (FI)
Inventor: HAKALA-RANTA ANTTI
IPC: H04J3/06
Filed: 2005-06-29
Abstract: The object of the invention is a module (1-6, 1-8, 1-10, 1- 12, 2-2 ... 2-16, 3-2) for an automation data transmission network, said module (1 -6, 1 -8, 1-10, 1-12, 2-2 ... 2-16, 3- 2) comprising an Ethernet switch (3-8). The invention is characterized in that the module comprises means (3-10, 3-12, 3-14) for receiving and transmitting a two-part time synchronization pulse in which the first and second part of the two-part time synchronization pulse jointly indicate time data so that the module (1-6, 1-8, 1-10, 1-12, 2-2 ... 2-16, 3-2) is adapted to receive time data from the first part and to convey the first part through the module's Ethernet switch (3-8), and the module (1-6, 1-8, 1-10, 1- 12, 2-2 ... 2-16, 3-2) is adapted to convey the second part past the module's Ethernet switch (3-8) and, in response to the second part, to synchronize itself with the time data indicated by the first part.
Patent IL-101311-A0 (IL)
Title: N-acyl-alpha-aminocarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IPC: C07D211/52
Filed: 1992-03-20
Abstract: N-Aroyl- alpha -aminocarboxylic acid derivatives of the formula <IMAGE> in which L, R' to R''' and Q have the meaning given in the description, can be used for the treatment or prophylaxis of diseases which are caused by the binding of adhesive proteins to blood platelets, as well as by blood platelet aggregation and cell-cell adhesion. They are prepared by removing protective groups in appropriately protected compounds or by conversion of the cyano group to the amidino group in appropriate nitriles.
Patent IL-101931-A0 (IL)
Title: Processes for the diastereoselective synthesis of nucleosides,and hydrofuran derivatives for use therein
IPC: C07D341/00
Filed: 1992-05-20
Abstract: The present invention relates to highly diastereoselective processes for production of cis-nucleosides and nucleoside analogues and derivatives in high optical purity and intermediates useful in those processes.
Patent IL-106963-A0 (IL)
Title: Ureidoacetamide derivatives,their preparation and medicaments containing them
IPC: A61P25/00
Filed: 1993-09-09
Abstract: PCT No. PCT/FR93/00847 Sec. 371 Date Mar. 10, 1995 Sec. 102(e) Date Mar. 10, 1995 PCT Filed Sep. 6, 1993 PCT Pub. No. WO94/06825 PCT Pub. Date Mar. 31, 1994This invention relates to compounds of formula (I), in which R denotes a hydrogen atom or a methoxy radical. The invention also concerns the salts of said compounds, their racemic forms, their enantiomers, the preparation of said derivatives and drugs containing same.
Patent IL-109227-A0 (IL)
Title: Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof
IPC: A61P7/02
Filed: 1994-04-05
Abstract: A new compound, which we have named Leustroducsin H, has formula (I) : <CHEM> and pharmaceutically acceptable salts thereof. This compound may be prepared by hydrolysis of naturally occurring Leustroducsins and the compound may be used for the treatment or prophylaxis of thrombocytopenia.
Patent IL-112048-A0 (IL)
Title: Methods of inhibiting thrombin
IPC: A61P43/00
Filed: 1994-12-19
Abstract: A method of inhibiting thrombin and its attending diseases and conditions comprising administering to a human in need of treatment an effective amount of a compound having the formula <CHEM>     wherein R<1> and R<3> are independently hydrogen, -CH3, <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidino, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Patent IL-112795-A0 (IL)
Title: Antithrombotic agents
IPC: A61K38/55
Filed: 1995-02-27
Abstract: This invention relates to thrombin inhibiting compounds haveing the Formula I X-Y-NH-(CH2)r-G where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containing those compounds and methods of their use as thrombin inhibitors, coagulation inhibitors, and thromboembolic disorder agents.
Patent IL-128804-A0 (IL)
Title: A method for generating birnavirus from synthetic rna transcripts
IPC: C12N15/09
Filed: 1997-07-31
Abstract: A system for the generation of live Birnavirus such as infectious bursal disease virus (IBDV), a segmented double-stranded (ds)RNA virus of the  Birnavirdae  family, using synthetic transcripts derived from cloned DNA has been developed. Independent full-length cDMA clones were constructed which contained the entire coding and noncoding regions of RNA segments A and B of IBDV, respectively. Synthetic RNAs of both segments were produced by  in viro  transcription of linearized plasmids with T7 RNA polymerase. Transfection of Vero cells with combined plus-sense transcripts of both segments generated infectious virus as early as 36 hours post-transfection. The development of a reverse genetics system for dsRNA viruses will greatly facilitate studies of the regulation of viral gene expression pathogenesis, and design of a new generation of live and inactivated vaccines.
Patent IL-134618-A0 (IL)
Title: Production of proteins in eggs
IPC: C12N5/10
Filed: 1998-08-21
Abstract: Methods for preparing recombinant proteins, such as antibodies, in eggs are described. The method offers advantages over existing systems for preparing recombinant proteins including high yield, low cost and compatibility with animal protection regulations. In addition, since eggs are edible food sources the recombinant protein does not have to be isolated from the egg.
Patent IL-139683-A0 (IL)
Title: Composition for the induction of a tumour-specific immune response, methods for its production and use of the composition for the treatment of neoplasia
IPC: A61K39/00
Filed: 1999-05-17
Abstract: A composition (I) comprising a phage or functionally equivalent fragment expressing at least one tumor-specific and/or tumor-associated antigen as a fusion protein, with a phage coat protein or derivative on its surface, is new. An Independent claim is also included for a method for the production of (I), comprising: (1) extraction of DNA from an individual tumor cell, so that the gene encoding the tumor-specific antigen can be amplified; (2) cloning, after digestion of the gene in a vector system with restriction enzymes and gel electrophoresis; and (3) expression of the gene as a phage fusion protein.
Patent IL-143968-A0 (IL)
Title: Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
IPC: C07D403/12
Filed: 1999-12-29
Abstract: The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
Patent IL-163584-A0 (IL)
Title: Ph-sensitive polymer
IPC: A61K31/7105
Filed: 2002-10-22
Abstract: A pH-sensitive polymer which has cytotoxic or membranolytic properties at pH values below pH 6.5. Carriers for natural or synthetic biomolecules or active pharmaceutical ingredients using such a pH-sensitive polymer.
Patent IL-183563-A0 (IL)
Title: New 3-phenylpropionic acid derivatives for the treatment of diabetes
Filed: 2007-05-30
Abstract: The invention relates to new compounds, being 3-phenylpropionic acid derivatives of formula I wherein W represents COOH group or its bioisosters, or —COO—C1-C4-alkyl group; Y represents NH, N—C1-C10-alkyl, O, or S; Z represents NH, N—C1-C10-alkyl, N-aryl, N-heteroaryl, S, or O; X represents O, S, NH, N—C1-C10-alkyl, N-aryl, NSO2—C1-C10-alkyl, N—SO2-aryl, or N—SO2-heteroaryl; R, to R8 each independently represent hydrogen atom or a substituent defined in the description; A is as defined in the description; n represents an integer from 0 to 4, inclusive; and pharmaceutically acceptable salts thereof. The compounds are the ligands of PPAR-gamma receptor and are useful as medicaments.
Patent AP-2002002611-A0 (AP)
Title: 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline mesylat and polymorphs.
Inventor: BASFORD PATRICIA ANN
IPC: A61K31/517
Filed: 2001-02-23
Abstract: The presentinvention provides 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylate of the formula (1)together with processes for preparing, and compositions containing it. The invention also relates to substancially pure anhydrous crystalline polymorphic forms of the free base. The compounds are particularly useful in the treatment of benign prostatic hyperplasia.
Patent MA-21758-A1 (MA)
Inventor: POWELL GAIL SCOTTON
IPC: A61K31/675
Filed: 1990-02-28
Abstract: The invention describes novel 3-cyano-4-sulfenylated-5-alkoxy-1-arylpyrazoles of general formula(I)   <CHEM>  wherein typically preferred substituents are:  R is C1 to C4 alkyl fully substituted by halogen; R1 is C1 to C4 alkyl, C3 to C6 alkenyl and alkynyl or aralkyl (each of which may be optionally substituted), dialkylaminocarbonyl or a group -P(=X)(Oalkyl)(Salkyl) wherein X is oxygen or sulfur;  R2, R3, R5 and R6 are each hydrogen or halogen;  R4 is CF3, OCF3, SCF3, SOCF3, SO2CF3, OCHF2, halogen or alkyl; and  n is 0, 1 or 2. The invention further relates to intermediates and processes to make the compounds as well as to compositions thereof and to methods of control of arthopod (especially insect) nematode, helminth, and protozoan pests.